Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simeprevir plus sofosbuvir for chronic genotype 4 hepatitis C virus infection
2014-003446-27Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simeprevir, sofosbuvir in hepatitis C virus infection, sponsored by Janssen Pharmaceutical. Started Oct 2014; status: completed.
02
Drugs
simeprevirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2014-003446-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003446-27.